ICAM1 and amyotrophic lateral sclerosis: In this study, we suggest combining levels of 3 biomarkers from serum (IFN-γ) and CSF (Nf-L and ICAM-1) that could improve diagnostic performance to distinguish ALS from some ALS mimic disorders.